It appears to be happening again. The
government is riding in on a white horse it calls patient safety to saddle us
with regulations that don't make sense in the real world of ophthalmology. The
FDA has issued a new set of rules that govern the reuse of disposable devices.
For now, the rules are aimed only at
hospitals and companies that reprocess single-use devices (SUDs), but comments
from FDA officials and our past experiences in similar situations leave little
doubt that they will eventually be applied to ambulatory surgery centers (ASCs)
as well.
The rules are onerous; hospitals will have
extreme difficulty complying. And the cost of compliance would force ASC owners
to discontinue reuse altogether. This would rob ophthalmic surgeons of one more
way to function cost-effectively, which in the long run benefits patients and
the profession as a whole. Doctors who can't turn a profit abandon all but the
simplest of care. Future advances are stifled. Furthermore, rather than
prompting surgeons to buy a new disposable device for each case, the result of
the regulations would be a widespread preference for nondisposable devices and
a subsequent loss of market share for SUD manufacturers. So, nobody really
benefits.
Laws should be backed by logic
No doctor would say that ophthalmology
should be free of regulation. But it's true that some devices labeled "for
single use" can be cleaned, sterilized and reused with no detrimental
effects on patients. This is what makes the current regulatory effort misguided
-- it's being mounted by entities who have little understanding of what they're
trying to regulate. It's reminiscent of the unnecessary pre-op medical testing
that was being done for cataract surgery in the past. The government was
spending, by conservative estimates, $250 million a year for something that has
been proven to provide no benefit to patients. Standard of care -- or worse
yet, laws -- should never be established based on nothing more than medical
custom or a knee-jerk reaction to a perceived problem. We can't afford that in
these cost-conscious times.
For guidance on the issue of reuse, we
should be turning to leaders in ophthalmology, organizations such as ASCRS,
OOSS, ACES and the AAO, who understand the issues involved and can help
regulators comprehend that when it comes to government interference in the
delivery of medical care, less is more